Quote | Vera Therapeutics Inc. (NASDAQ:VERA)
Last: | $34.89 |
---|---|
Change Percent: | -0.49% |
Open: | $35.1 |
Close: | $34.89 |
High: | $35.33 |
Low: | $34.49 |
Volume: | 375,922 |
Last Trade Date Time: | 07/03/2024 03:00:00 am |
News | Vera Therapeutics Inc. (NASDAQ:VERA)
2024-07-01 08:15:40 ET More on Vera Therapeutics Vera Therapeutics: Waiting For A Pullback Vera gains FDA Breakthrough Therapy Designation for atacicept Read the full article on Seeking Alpha For further details see: Vera Therapeutics appoints David Johns...
BRISBANE, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the appointment of David L....
Message Board Posts | Vera Therapeutics Inc. (NASDAQ:VERA)
Subject | By | Source | When |
---|---|---|---|
whytestocks: $VERA News Article - Vera Therapeutics Completes Patient Enrollment in Phase 2b ORIGIN | whytestocks | investorshangout | 07/06/2022 2:40:53 PM |
whytestocks: $VERA News Article - Vera Therapeutics Announces Closing of Upsized Public Offering of | whytestocks | investorshangout | 02/14/2022 9:30:49 PM |
whytestocks: $VERA News Article - Vera Therapeutics Hosting Key Opinion Leader Webinar on IgA Nephro | whytestocks | investorshangout | 09/09/2021 5:40:58 PM |
Stock_Tracker: Latest Veramark Techs Inc (VERA) Headlines Calero Software is Launched from the Merge | Stock_Tracker | investorshangout | 03/12/2014 4:42:37 AM |
$VERA: Merged with TEM Holdings Inc. for $1.18 | Renee | investorshub | 07/22/2013 11:33:11 PM |
News, Short Squeeze, Breakout and More Instantly...
Vera Therapeutics Inc. Company Name:
VERA Stock Symbol:
NASDAQ Market:
Vera Therapeutics Inc. Website:
BRISBANE, Calif., July 01, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the appointment of David L....
2024-06-15 11:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
BRISBANE, Calif., June 11, 2024 (GLOBE NEWSWIRE) -- Vera Therapeutics, Inc. (Nasdaq: VERA), a late clinical-stage biotechnology company focused on developing and commercializing transformative treatments for patients with serious immunological diseases, today announced the appointment of Christy ...